Drawing for TESSARA

USPTO serial 79289716

TESSARA

Reviewed by CopyMark Law Group

Reg. 6358467Status 700Renewal
Filing date
Status date
Registration date
May 25, 2021
Examiner
MCCAULEY, BRENDAN D
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TESSARA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles G. Zug

Charles G. Zug Nelson Mullins Riley & Scarborough LLP301 S. College St.Suite 2300, IP DepartmentCharlotte, NC 28202

Goods and services

ClassDescriptionStatusFirst use
042Scientific research and development; biotechnology research and development; analysis of human tissues for medical research; biological sample analysis for scientific and medical research purposes; product development of diagnostic apparatuses; pharmaceutical drug development services; pharmaceutical research and development; product development consultancy relating to research and development in the field of therapeutics; medical, scientific, and new product research in the field of gene therapy; providing new products testing, quality testing and safety testing in the fields of scientific and medical research relating to research and development of medicines, drug discovery, pharmaceutical drug development and drug screening for scientific research purposes and consultancy related thereto; scientific research relating to the isolation and cultivation of human tissues and cellsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 25, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 10, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 4, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 16, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 16, 2021FIMPFINAL DISPOSITION PROCESSED—
Aug 25, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 25, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 15, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 2, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 1, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 1, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 5, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 26, 2020RFRRREFUSAL PROCESSED BY MPU—
Jul 25, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 22, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 21, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2020DOCKASSIGNED TO EXAMINER—
Jul 21, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 16, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance